Home › NDC Lookup › Ingredients › Calcitriol › 72789-0058-01
💊image loading
(from DailyMed)

Calcitriol .25 ug Capsule, 100-count — NDC 72789-058-01 (Billing 72789-0058-01)

by PD-Rx Pharmaceuticals, Inc. · 100 CAPSULE in 1 BOTTLE, PLASTIC

This is a package of 100 capsules of Calcitriol .25 ug Capsule from PD-Rx Pharmaceuticals, Inc., marketed since Mar 2006 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 72789-0058-01
🏷️ FDA NDC (as labeled) 72789-058-01 billing pads the product segment with a zero
This package
Contains100-count Pack sizes2 compare ↓
Also priced by: Part D plans $0.3665/unit — full pricing hub ↓
Main listing for product 72789-058 · Also comes in: 30 capsules 72789-058-30
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 72789-058-01 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
72789 labeler · 058 product · 01 package
Package marketed since
Feb 26, 2020
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 7278905801 6
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 72789-058-01
Product NDC 72789-058
11-digit billing NDC 72789005801
NCPDP billing unit EA — each (per item)
Application # ANDA076917
SPL Set ID 5b739d24-5f7b-b971-e063-6294a90a031f
Established class (EPC) Vitamin D3 Analog
Chemical class Cholecalciferol
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2006-03-27
Route ORAL
Dosage form CAPSULE
Substance CALCITRIOL
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 002184
GCN 94481
HICL code 000999
Ingredient (HICL) Calcitriol
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C6
Therapeutic class — intermediate (HIC2) Vitamins
HIC3 code C6D
Therapeutic class — specific (HIC3) Vitamin D Preparations
AHFS code 88:16.00.00
AHFS class Vitamin D
FDB label name CALCITRIOL 0.25 MCG CAPSULE
FDB brand name Calcitriol
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 002184
  • GCN: 94481
  • HICL (First Databank): 000999
  • AHFS class code: 88:16.00.00
Why two NDCs? The FDA registers this code as 72789-058-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72789-0058-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name CALCITRIOL 0.25 MCG CAPSULE Ingredient Calcitriol
📖 What it is MedlinePlus · NLM

Calcitriol is used to treat and prevent low levels of calcium and bone disease in patients whose kidneys or parathyroid glands (glands in the neck that release natural substances to control the amount of calcium in the blood) are not working normally. It is also used to treat secondary hyperparathyroidism (a condition in which the body produces too much parathyroid hormone [PTH; a natural substance needed to control the amount of calcium in the blood]) and metabolic bone disease in people with kidney disease. Calcitriol is in a class of medications called vitamin D analogs. It works by helping...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • The oral forms and the injection manage low calcium and bone problems tied to kidney disease, dialysis or low parathyroid function. The ointment is a different use: it treats mild...
  • Take it exactly as your prescriber directs. Oral forms are taken by mouth, the injection is given into a vein, and the ointment goes on affected skin twice daily. Your doctor will...
  • Yes. You need enough calcium, but not too much. Avoid adding calcium supplements or other vitamin D products unless your doctor says so, since they can push calcium too high.
  • Call if you have weakness, nausea, vomiting, constipation, bone pain, headache, or heavy thirst and urination. These can signal high calcium. Rash, hives or swelling of the lips ar...
📖 Read our full Calcitriol guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.3665 $36.65 / 100 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
72789-0058-01 You're viewing this Main listing 100 CAPSULE in 1 BOTTLE, PLASTIC 2020-02-26 — Active
72789-0058-30 72789-058-30 30 CAPSULE in 1 BOTTLE, PLASTIC 2023-07-14 — Active

You're viewing the largest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 capsule in 1 bottle, plastic.
How does this package differ from NDC 72789-0058-30?
Both are Calcitriol .25 ug Capsule — the drug itself is identical. This page's package is the 100-count one, while NDC 72789-0058-30 is the 30 capsules package.
What NDC number is used to bill for this package of Calcitriol .25 ug Capsule?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Calcitriol .25 ug 00093-7352-01 Teva 100 capsules $0.153 AB Availability likely —
Calcitriol .25 ug 23155-0662-01 Heritage 100 capsules $0.153 AB Availability likely —
Calcitriol .25 ug 42806-0732-01 EPIC 100 capsules $0.153 AB Availability likely —
Calcitriol .25 ug 60687-0345-01 American 100 capsules $0.153 AB Availability likely —
Calcitriol .25 ug 62135-0610-90 Chartwell 90 capsules $0.153 AB Availability likely —
Calcitriol .25 ug 64380-0723-04 Strides 30 capsules $0.153 AB Availability likely —
Calcitriol .25 ug 69452-0207-13 BIONPHARMA 30 capsules $0.153 AB Availability likely —
Calcitriol .25 ug 00054-0007-13 Hikma 30 capsules $0.161 AB Availability likely —
Calcitriol .25 ug 50090-6711-00 A-S 30 capsules — AB FDA listed —
Calcitriol .25 ug 50090-7470-00 A-S 30 capsules — AB FDA listed —
Calcitriol .25 ug 51407-0169-01 Golden 100 capsules — AB FDA listed —
Calcitriol .25 ug 55154-8186-00 Cardinal 10 capsules — AB FDA listed —
Calcitriol .25 ug 62756-0967-18 Sun 1000 capsules — — FDA listed —
Calcitriol .25 ug 63304-0239-01 Sun 100 capsules — AB Discontinued —
Calcitriol .25 ug 63629-7323-01 Bryant 30 capsules — AB FDA listed —
Calcitriol .25 ug 63629-8741-01 Bryant 100 capsules — AB FDA listed —
Calcitriol .25 ug 65162-0519-03 Amneal 30 capsules — AB FDA listed —
Calcitriol .25 ug 71610-0468-09 Aphena 9000 capsules — AB FDA listed —
Calcitriol .25 ug 71610-0521-09 Aphena 9000 capsules — AB FDA listed —
Calcitriol .25 ug 71610-0870-30 Aphena 30 capsules — AB FDA listed —
Calcitriol .25 ug 72162-1031-01 Bryant 100 capsules — AB FDA listed —
Calcitriol .25 ugthis 72789-0058-01 PD-Rx 100 capsules — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2006
On the market since
Mar 2006
📍
2026
Currently FDA-listed
20 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Calcitriol inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPD-Rx Pharmaceuticals, Inc.
Application holderHIKMA PHARMACEUTICALS USA INC
FDA applicationANDA076917 (ANDA)
Labeler code72789
First marketedMar 2006
Product typeHuman Prescription Drug
Portfolio835 products on file

More NDCs from PD-Rx Pharmaceuticals, Inc. labeler code 72789

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Calcitriol — the program that covers self-administered drugs. 11 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Calcitriol. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$7.16M
Claims incl. refills
342.9K
Beneficiaries
241.8K
Spend / beneficiary
$29.60
Spend / claim
$20.88
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by PD-Rx Pharmaceuticals, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 30 capsules (72789-0058-30). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
PD-Rx Pharmaceuticals, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 72789-0057-01 · PD-Rx 72789-0061-20 · PD-Rx →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.